balance equationreview2016-12-31
Difference 29900000 exceeds tolerance 18330200.000. Presentation or filing-vintage differences need review.
Revenue
$16.08B
Fiscal year ended 2025-12-31Operating income
$2.74B
Fiscal year ended 2025-12-31Free cash flow
$1.90B
Fiscal year ended 2025-12-31ECOLAB INC. (ECL) reported revenue of $16.08B and net income of $2.08B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ECOLAB INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.08B | $15.74B | $15.32B | $14.19B | $12.73B | $11.79B | $12.56B | $12.22B | $13.84B | $13.15B |
| Cost of revenue | $8.93B | $8.90B | $9.15B | $8.83B | $7.62B | $6.91B | $7.05B | $6.88B | $8.06B | $7.53B |
| Gross profit | $7.15B | $6.84B | $6.17B | $5.36B | $5.12B | $4.88B | $5.52B | $5.35B | $5.77B | $5.62B |
| Operating income | $2.74B | $2.80B | $1.99B | $1.56B | $1.60B | $1.40B | $1.85B | $1.73B | $1.95B | $1.87B |
| Net income | $2.08B | $2.11B | $1.37B | $1.09B | $1.13B | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Research & development | $202.00M | $207.00M | $192.00M | $190.00M | $186.00M | $185.00M | $190.00M | $193.00M | $201.00M | $189.00M |
| Weighted-average diluted shares | shares 285.20M | shares 286.60M | shares 286.50M | shares 286.60M | shares 289.10M | shares 290.30M | shares 292.50M | shares 292.80M | shares 294.00M | shares 296.70M |
| Pretax income | $2.55B | $2.57B | $1.76B | $1.34B | $1.41B | $1.16B | $1.73B | $1.59B | $1.76B | $1.65B |
| Income tax expense | $454.60M | $439.30M | $362.50M | $234.50M | $270.20M | $176.60M | $288.60M | $321.20M | $243.80M | $402.90M |
| Diluted EPS | $7.28 | $7.37 | $4.79 | $3.81 | $3.91 | $-4.15 | $5.33 | $4.88 | $5.12 | $4.14 |
| Selling, general & administrative | $4.26B | $4.23B | $4.06B | $3.65B | $3.42B | $3.31B | $3.55B | $3.51B | $3.83B | $3.71B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $646.20M | $1.26B | $919.50M | $598.60M | $359.90M | $1.26B | $118.80M | $114.70M | $211.40M | $327.40M |
| Total assets | $24.70B | $22.39B | $21.85B | $21.46B | $21.21B | $18.13B | $20.87B | $20.07B | $19.96B | $18.33B |
| Current assets | $5.96B | $6.03B | $5.64B | $5.49B | $4.69B | $5.12B | $4.83B | $4.68B | $4.59B | $4.28B |
| Total liabilities | $14.89B | $13.60B | $13.77B | $14.21B | $13.95B | $11.92B | $12.14B | $12.02B | $12.31B | $11.36B |
| Current liabilities | $5.53B | $4.79B | $4.35B | $4.21B | $3.55B | $2.93B | $3.63B | $3.69B | $3.48B | $3.02B |
| Total equity incl. NCI | $9.80B | $8.79B | $8.07B | $7.26B | $7.25B | $6.20B | $8.73B | $8.05B | $7.65B | $6.94B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.49B | $1.46B | $1.50B | $1.79B | $1.49B | $1.29B | $1.08B | $1.55B | $1.45B | $1.32B |
| Accounts receivable | $3.25B | $2.86B | $2.83B | $2.70B | $2.48B | $2.27B | $2.38B | $2.66B | $2.57B | $2.34B |
| Goodwill | $9.23B | $7.91B | $8.15B | $8.01B | $8.06B | $6.01B | $5.57B | $5.39B | $7.17B | $6.38B |
| Long-term debt | $7.37B | $6.95B | $7.55B | $8.08B | $8.35B | $6.67B | $5.97B | $6.30B | $6.76B | $6.15B |
| Accounts payable | $2.07B | $1.81B | $1.57B | $1.73B | $1.38B | $1.16B | $1.08B | $1.26B | $1.18B | $983.20M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.95B | $2.81B | $2.41B | $1.79B | $2.06B | $1.86B | $2.42B | $2.28B | $2.09B | $1.94B |
| Capital expenditures | $1.05B | $994.50M | $774.80M | $712.80M | $643.00M | $489.00M | $731.30M | $778.70M | $868.60M | $756.80M |
| Investing cash flow | -$2.71B | -$433.80M | -$990.50M | -$716.80M | -$4.58B | -$414.50M | -$1.20B | -$1.03B | -$1.73B | -$773.60M |
| Financing cash flow | -$853.30M | -$2.02B | -$1.05B | -$837.30M | $1.60B | -$341.80M | -$1.35B | -$1.17B | -$522.70M | -$868.20M |
| Net change in cash | Unavailable | Unavailable | $320.90M | $238.70M | -$900.30M | $1.07B | -$107.60M | $82.60M | -$169.00M | $287.60M |
| Stock-based compensation | $136.60M | $134.80M | $95.10M | $87.80M | $89.50M | $82.10M | $84.00M | $88.00M | $90.50M | $85.70M |
| Common dividends paid | $753.60M | $664.30M | $617.30M | $602.80M | $566.40M | $560.80M | $552.90M | $494.80M | $448.70M | $427.50M |
| Common share repurchases | $783.80M | $986.50M | $13.70M | $518.20M | $106.60M | $146.20M | $353.70M | $562.40M | $600.30M | $739.60M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.90B | $1.82B | $1.64B | $1.08B | $1.42B | $1.37B | $1.69B | $1.50B | $1.22B | $1.18B |
| Gross margin | 44.5% | 43.5% | 40.2% | 37.8% | 40.2% | 41.4% | 43.9% | 43.7% | 41.7% | 42.7% |
| Operating margin | 17.0% | 17.8% | 13.0% | 11.0% | 12.6% | 11.8% | 14.7% | 14.1% | 14.1% | 14.2% |
| FCF margin | 11.8% | 11.6% | 10.7% | 7.6% | 11.1% | 11.6% | 13.4% | 12.3% | 8.8% | 9.0% |
| SBC / revenue | 0.8% | 0.9% | 0.6% | 0.6% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% |
| Current ratio | 1.08x | 1.26x | 1.30x | 1.30x | 1.32x | 1.75x | 1.33x | 1.27x | 1.32x | 1.42x |
| Revenue YoY growth | 2.2% | 2.7% | 8.0% | 11.4% | 8.0% | -6.1% | 2.8% | -11.7% | 5.2% | Unavailable |
| Net margin | 12.9% | 13.4% | 9.0% | 7.7% | 8.9% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | 1.3% | 1.3% | 1.3% | 1.3% | 1.5% | 1.6% | 1.5% | 1.6% | 1.5% | 1.4% |
| CapEx / revenue | 6.5% | 6.3% | 5.1% | 5.0% | 5.0% | 4.1% | 5.8% | 6.4% | 6.3% | 5.8% |
| Long-term debt / equity | 0.75x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 17.8% | 17.1% | 20.6% | 17.5% | 19.1% | 15.2% | 16.7% | 20.2% | 13.8% | 24.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ECL in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-23View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.